Modulation of apolipoprotein C-III expression
First Claim
Patent Images
1. A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding apolipoprotein C-III, wherein said compound specifically hybridizes with said nucleic acid molecule encoding apolipoprotein C-III (SEQ ID NO:
- 4) and inhibits the expression of apolipoprotein C-III.
2 Assignments
0 Petitions
Accused Products
Abstract
Compounds, compositions and methods are provided for modulating the expression of apolipoprotein C-III. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein C-III. Methods of using these compounds for modulation of apolipoprotein C-III expression and for diagnosis and treatment of disease associated with expression of apolipoprotein C-III are provided.
-
Citations
52 Claims
-
1. A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding apolipoprotein C-III, wherein said compound specifically hybridizes with said nucleic acid molecule encoding apolipoprotein C-III (SEQ ID NO:
- 4) and inhibits the expression of apolipoprotein C-III.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)
-
19. A method of screening for a modulator of apolipoprotein C-III, the method comprising the steps of:
-
a. contacting a preferred target segment of a nucleic acid molecule encoding apolipoprotein C-III with one or more candidate modulators of apolipoprotein C-III, and b. identifying one or more modulators of apolipoprotein C-III expression which modulate the expression of apolipoprotein C-III. - View Dependent Claims (20)
-
-
21. A diagnostic method for identifying a disease state comprising identifying the presence of apolipoprotein C-III in a sample using at least one of the primers comprising SEQ ID NOs 5 or 6, or the probe comprising SEQ ID NO 7.
Specification